Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells

Journal of Biomedical Science

Volumn 11, Issue 1, 2004, Pages 104-116

  Liu, Cheng Chung ^a,b   Chou, Yu Ling ^b   Ch'ang, Lan Yang ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Bone marrow; CD34+ cells; Cord blood; Down regulation of NDR; K562 cells; Megakaryocytic differentiation; Negative differentiation regulator (NDR) gene

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ANTISERUM; CD34 ANTIGEN; CD61 ANTIGEN; FIBRINOGEN RECEPTOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SELECTION; CORRELATION ANALYSIS; CYTOPLASM; DOWN REGULATION; ERYTHROLEUKEMIA CELL; FETUS; FETUS LIVER; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPHOID TISSUE; MEGAKARYOCYTE; MOUSE; NEGATIVE DIFFERENTIATION REGULATOR GENE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATOR GENE; TESTIS; UMBILICAL CORD BLOOD;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; DOWN-REGULATION; FETAL BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; HUMANS; INTEGRIN BETA3; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MEGAKARYOCYTES; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PLATELET MEMBRANE GLYCOPROTEIN IIB; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; TETRADECANOYLPHORBOL ACETATE; TISSUE DISTRIBUTION;

EID: 0942268175     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000075293     Document Type: Article

References (35)

1. Alitalo R. Induced differentiation of K562 leukemia cells: A model for studies of gene expression in early megakaryoblasts. Leuk Res 14:501-514;1990.
2. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842-845;1986.
3. Buske C, Feuring-Buske M, Abramovich C, Spiekermann K, Eaves CJ, Coulombel L, Sauvageau G, Hogge DE, Humphries RK. Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100:862-868;2002.
4. Buske C, Feuring-Buske M, Antonchuk J, Rosten P, Hogge DE, Eaves CJ, Humphries RK. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood 97:2286-2292;2001.
5. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157-165;1984.
6. Fujino T, Yamazaki Y, Largaespada DA, Jenkins NA, Copeland NG, Hirokawa K, Nakamura T. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes. Exp Hematol 29:856-863;2001.
7. Herrera R, Hubbell S, Decker S, Petruzzelli L. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 238:407-414;1998.
8. Kao YS, Sartin BW, Van Brunt J, Hew AY. Interstitial 9q deletion (q12q22) in two cases of acute myeloblastic leukemia. Cancer Genet Cytogenet 19:365-366;1986.
9. Kruger A, Ellerstrom C, Lundmark C, Christersson C, Wurtz T. RP59, a marker for osteoblast recruitment, is also detected in primitive mesenchymal cells, erythroid cells, and megakaryocytes. Dev Dyn 223:414-418;2002.
10. Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:1922-1930;1997.
11. Long MW, Heffner CH, Williams JL, Peters C, Prochownik EV. Regulation of megakaryocyte phenotype in human erythroleukemia cells. J Clin Invest 85:1072-1084;1990.
12. Lumelsky NL, Schwartz BS. Protein kinase C in erythroid and megakaryocytic differentiation: Possible role in lineage determination. Biochim Biophys Acta 1358:79-92;1997.
13. Mitelman F. Catalog of chromosome aberrations in cancer. Wiley-Liss, New York. 1991.
14. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474;1997.
15. Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C, Kinsey S, Rhodes M, Layton DM. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet 64:165-171;1999.
16. Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci USA 92:4601-4605;1995.
17. Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM, Nienhuis AW. Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood 93:488-499;1999.
18. Racke FK, Lewandowska K, Goueli S, Goldfarb AN. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for mega-karyocytic differentiation of K562 cells. J Biol Chem 272:23366-23370;1997.
19. Sanford JS, Hirokazu K, Nisar P. Integrin signaling: The platelet paradigm. Blood 91:2645-2657;1998.
20. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91: 12223-12227;1994.
21. Sauvageau G, Thorsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Lansdorp PM, Humphries RK. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 9:1753-1765;1995.
22. + stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood 97:426-434, 2001.
23. Sreekantaiah C, Baer MR, Preisler HD, Sandberg AA. Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemia. Cancer Genet Cytogenet 39:55-64;1989.
24. Sutherland JA, Turner AR, Mannoni P, McGann LE, Turc JM. Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod 5:250-262;1986.
25. Tabilio A, Pelicci PG, Vinci G, Mannoni P, Civin CI, Vainchenker W, Testa U, Lipinski M, Rochant H, Breton-Gorius J. Myeloid and megakaryocytic properties of K-562 cell lines. Cancer Res 43:4569-4574;1983.
26. Tetteroo PA, Massaro F, Mulder A, Schreudervan Gelder R, von dem Borne AE. Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk Res 8:197-206; 1984.
27. Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C, Humphries RK. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol. 17:495-505;1997.
28. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221-226;1994.
29. Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:3636-3643;1997.
30. Tsai RY, McKay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 16:2991-3003;2002.
31. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of the transcription factor PU.1. Proc Natl Acad Sci USA 91:7932-7936;1994.
32. Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS, Ahn NG. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol 17:1947-1958;1997.
33. Wurtz T, Kruger A, Christersson C, Lundmark C. A new protein expressed in bone marrow cells and osteoblasts with implication in osteo-blast recruitment. Exp Cell Res 263:236-242;2001.
34. Yang LV, Nicholson RH, Kaplan J, Galy A, Li L. Hemogene is a novel nuclear factor specifically expressed in mouse hematopoietic development and its human homologue EDAG maps to chromosome 9q22, a region containing breakpoints of hematological neoplasms. Mech Dev 104:105-111;2001.
35. Yunis JJ, Bruning RD, Howe RB, Lobel M. High-resolution chromosomes as an independent prognostic indicator in adult acute non-lymphocytic leukemia. N Engl J Med 311:812-818;1984.